A new testing method can be used to detect accurately the indications sent out by an individual's immune system to be something as cancerous.

Early research is of the suggestion that the indications can be detected up to five years prior to a tumor is spotted, offering doctors and patients a fundamental headstart in treating the sickness.

The test, which has been developed by clinicians in Nottingham and Kansas over a period of 15 years, is to be introduced in America in the later part of this month.

It initially had been devised, in order to detect lung cancer and is put in usage alongside conventional screening.

The technology had been developed by scientists at the University of Nottingham and Oncimmune, a medical research corporation.

The test works by recognising how the immune system reacts to the first molecular signs of cancer development.

Cancerous cells generate little amounts of protein material named as antigens, which prompts the immune system to generate great amounts of auto-antibodies.

Professor John Robertson, a Breast Cancer Specialist who led the research, said that the earliest cancer that has been seen by him and his team has been detected and yet biologically, that proved to be quite late in the road of cancer development.